Published in Wiley Interdiscip Rev Nanomed Nanobiotechnol on June 24, 2010
Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Blood Substit Immobil Biotechnol (2011) 0.91
Poly(ethylene glycol) cross-linked hemoglobin with antioxidant enzymes protects pancreatic islets from hypoxic and free radical stress and extends islet functionality. Biotechnol Bioeng (2012) 0.77
Investigation on artificial blood or substitute blood replace the natural blood. Iran J Ped Hematol Oncol (2014) 0.75
Nanobiotechnological Nanocapsules Containing Polyhemoglobin-Tyrosinase: Effects on Murine B16F10 Melanoma Cell Proliferation and Attachment. J Skin Cancer (2012) 0.75
Nanobiotechnology and blood substitutes. Asian J Transfus Sci (2011) 0.75
Bio-inspired nanomedicine strategies for artificial blood components. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2017) 0.75
Extraction of Phospholipids from Human Erythrocyte Membranes by Hemoglobin Oxidation Products. J Membr Biol (2016) 0.75
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA (2008) 8.60
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11
SEMIPERMEABLE MICROCAPSULES. Science (1964) 2.91
Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov (2005) 2.56
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg (2008) 1.86
Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol (1998) 1.81
Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation (2008) 1.60
Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Commun (1971) 1.41
Myoglobin and haemoglobin: role of distal residues in reactions with haem ligands. Trends Biochem Sci (1989) 1.39
Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. J Pharmacol Exp Ther (1999) 1.38
Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol (1980) 1.24
HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma (2008) 1.23
Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report. Artif Cells Blood Substit Immobil Biotechnol (1994) 1.19
Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. J Bioeng (1976) 1.17
First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives. Expert Opin Biol Ther (2007) 1.13
Nanobiotechnological modification of hemoglobin and enzymes from this laboratory. Biochim Biophys Acta (2008) 1.04
Clinical development of human polymerized hemoglobin as a blood substitute. World J Surg (1996) 1.01
Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif Cells Blood Substit Immobil Biotechnol (2002) 1.01
Effects of PEG-PLA-nano artificial cells containing hemoglobin on kidney function and renal histology in rats. Artif Cells Blood Substit Immobil Biotechnol (2008) 0.99
Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram. Artif Cells Blood Substit Immobil Biotechnol (2006) 0.99
Polyhemoglobin-fibrinogen: a novel oxygen carrier with platelet-like properties in a hemodiluted setting. Artif Cells Blood Substit Immobil Biotechnol (2007) 0.99
In vitro and in vivo effects of polyhaemoglobin-tyrosinase on murine B16F10 melanoma. Melanoma Res (2004) 0.98
A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified Hemoglobin (Hemospan) in patients undergoing major orthopedic surgery. Anesthesiology (2006) 0.98
50th anniversary of artificial cells: their role in biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy and nanorobotics. Artif Cells Blood Substit Immobil Biotechnol (2007) 0.96
Polynitroxyl hemoglobin: a pharmacokinetic study of covalently bound nitroxides to hemoglobin platforms. Free Radic Biol Med (2004) 0.95
Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. Artif Cells Blood Substit Immobil Biotechnol (1996) 0.92
Long-term effects on the histology and function of livers and spleens in rats after 33% toploading of PEG-PLA-nano artificial red blood cells. Artif Cells Blood Substit Immobil Biotechnol (2008) 0.92
Effects of polyhemoglobin-antioxidant enzyme complex on ischemia-reperfusion in kidney. Transplant Proc (2004) 0.91
Biocompatible and biodegradable polymersome encapsulated hemoglobin: a potential oxygen carrier. Bioconjug Chem (2008) 0.88
Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase. Artif Cells Blood Substit Immobil Biotechnol (2009) 0.85
Hemoglobin-vesicles as a transfusion alternative. Artif Cells Blood Substit Immobil Biotechnol (2006) 0.85
Hemoglobin vesicles containing methemoglobin and L-tyrosine to suppress methemoglobin formation in vitro and in vivo. Bioconjug Chem (2006) 0.80
Blood transfusion in patients with acute coronary syndrome. JAMA (2005) 0.79